Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference
Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that management will ...